These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
75 related articles for article (PubMed ID: 5883468)
1. Influence of chemotherapy on the progress and survival rate in plasmocytoma. Gerhartz H; Obrecht P; Ramsbott C Antimicrob Agents Chemother (Bethesda); 1965; 5():514-7. PubMed ID: 5883468 [No Abstract] [Full Text] [Related]
2. [Therapy of plasmacytoma]. Fateh-Moghadam A Munch Med Wochenschr; 1973 May; 115(18):861-4. PubMed ID: 4800218 [No Abstract] [Full Text] [Related]
3. Therapeutic results in paraproteinemic diseases and immunoreactions during treatment with cytostatic agents. Kessel M; Gerhartz H; Taguchi J; Taguchi T Antimicrob Agents Chemother (Bethesda); 1965; 5():518-23. PubMed ID: 5327521 [No Abstract] [Full Text] [Related]
4. [Duration of disease and survival time in plasmacytoma]. Rautenstrauch H Z Gesamte Inn Med; 1970 Dec; 25(23):1071-4. PubMed ID: 5512749 [No Abstract] [Full Text] [Related]
5. [Therapy of hemoblastoses. V. Plasmocytoma and macroglobulinemic reticulosis of Walderström]. Danieli G G Clin Med; 1967 Feb; 48(2):164-74. PubMed ID: 4971622 [No Abstract] [Full Text] [Related]
6. [On the control of the disease course and life expectation in plasmacytoma patients by chemotherapy]. Gerhartz H; Obrecht P; Ramsbott C Verh Dtsch Ges Inn Med; 1965; 71():496-8. PubMed ID: 5877663 [No Abstract] [Full Text] [Related]
7. Immunosuppressants in systemic vasculitides. Guillevin L Isr Med Assoc J; 2000 Dec; 2 Suppl():27-8. PubMed ID: 11344865 [No Abstract] [Full Text] [Related]
8. [Pharmacological treatment of patients with plasmacytoma]. Piotrowska-Sowińska J; Anisimowicz J; Hellman A; Chodorowski Z; Lawinska-Stankiewicz S Pol Arch Med Wewn; 1977 Jan; 57(1):13-9. PubMed ID: 834580 [No Abstract] [Full Text] [Related]
10. [Problems of immunoglobulin analysis in IgD-plasmacytoma]. Kühn RA; Kunstmann FW; Syrbe G Z Gesamte Inn Med; 1980 Sep; 35(18):718-20. PubMed ID: 6778001 [TBL] [Abstract][Full Text] [Related]
11. Pulmonary and intracerebral plasmacytomas in a patient without multiple myeloma: a case report. Hayes-Lattin B; Blanke CD; Deloughery TG Am J Hematol; 2003 Jun; 73(2):131-4. PubMed ID: 12749016 [TBL] [Abstract][Full Text] [Related]
12. [A case of solitary myeloma (BJ-lambda) showing marked morphological changes]. Fujii H; Seki S; Suyama Y; Shimizu T; Kano T; Yasuda N Gan No Rinsho; 1983 Apr; 29(4):A-22, 342-8. PubMed ID: 6854970 [TBL] [Abstract][Full Text] [Related]
13. [Diagnosis and treatment of malignant lymphomas]. Märki HH Folia Clin Int (Barc); 1967 Sep; 17(9):423-4. PubMed ID: 5616122 [No Abstract] [Full Text] [Related]
14. Success and failure in the treatment of solid tumors. I. Effects of cyclophosphamide (NSC-26271) on primary and metastatic plasmacytoma in the hamster. Griswold DP; Schabel FM; Wilcox WS; Simpson-Herren L; Skipper HE Cancer Chemother Rep; 1968 Apr; 52(3):345-87. PubMed ID: 5670719 [No Abstract] [Full Text] [Related]
15. [Problem of therapeutic tactics in plasmacytoma]. Klener P Vnitr Lek; 1974 Jul; 20(6):567-72. PubMed ID: 4844791 [No Abstract] [Full Text] [Related]
16. Long-term survival of patients with Wegener's granulomatosis. Iacovino JR J Insur Med; 2000; 32(4):249-53. PubMed ID: 16104371 [No Abstract] [Full Text] [Related]
17. Factors predictive of remission in steroid resistant nephrotic syndrome in children: a multivariate analysis. Gulati S; Saha A Indian Pediatr; 2007 May; 44(5):395-6. PubMed ID: 17536147 [No Abstract] [Full Text] [Related]
18. Development and characterization of a cyclophosphamide-resistant mouse plasmacytoma cell line. Frondoza CG; Trivedi SM; Humphrey RL Cancer Treat Rep; 1982 Jul; 66(7):1535-44. PubMed ID: 7093969 [TBL] [Abstract][Full Text] [Related]